STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Clinical trials for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to boost mesothelioma surgery success
Disease control OngoingThis early-phase trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy (cisplatin and pemetrexed) before and after surgery can help people with resectable pleural mesothelioma. The study includes 28 participants with stage I-III disease. The…
Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for rare cancers: drug duo shows promise
Disease control OngoingThis phase II trial tests whether combining two drugs, atezolizumab and bevacizumab, can shrink rare solid tumors like appendix cancer, anal cancer, and mesothelioma. About 133 participants with various rare cancers will receive the drugs intravenously. The goal is to see if the …
Matched conditions: STAGE III PLEURAL MALIGNANT MESOTHELIOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC